Current Oncology Reports

, Volume 7, Issue 6, pp 459–465

Quality of life and gynecologic malignancies

  • Charlotte C. Sun
  • Michael Frumovitz
  • Diane C. Bodurka
Article

DOI: 10.1007/s11912-005-0011-3

Cite this article as:
Sun, C.C., Frumovitz, M. & Bodurka, D.C. Curr Oncol Rep (2005) 7: 459. doi:10.1007/s11912-005-0011-3

Abstract

In 2005, an estimated 79,480 new cases of gynecologic malignancies will be diagnosed, and almost 29,000 women will die. Treatment of gynecologic malignancies involves a combination of surgery, chemotherapy, and/or radiotherapy, all of which may affect a woman’s physical, social, and emotional well-being. Although specific effects on quality of life (QOL) depend on disease site, treatment-, and patient-specific factors, common QOL issues include changes in physical functioning due to side effects of treatment, psychological distress due to fear and anxiety of recurrence, sexual dysfunction associated with anatomic and physiologic changes of treatment, and, for younger women, loss of childbearing potential. As new diagnostic and treatment strategies for gynecologic malignancies are developed, research efforts should include QOL consequences. Further studies are needed to develop strategies for identifying women at risk for serious QOL disruption so that effective interventions to assist these women can be designed.

Copyright information

© Current Science Inc 2005

Authors and Affiliations

  • Charlotte C. Sun
    • 1
  • Michael Frumovitz
    • 1
  • Diane C. Bodurka
    • 1
  1. 1.Department of Gynecologic OncologyThe University of Texas M.D. Anderson Cancer CenterHoustonUSA